Pharmacists in South Boston, Massachusetts


13 Pharmacists found in South Boston
male pharmacist

Dr. Christopher Francis Conboy, PHARMD


Pharmacist
710 E Broadway, South Boston, MA 02127
413-519-9671    

female pharmacist

Dr. Elexus Amberly Afonso, PHARMD


Pharmacist
423 W Broadway, South Boston, MA 02127
617-269-7656    

female pharmacist

Emma Oanh Nguyen


Pharmacist
423 W Broadway, South Boston, MA 02127
617-269-7656     617-269-8331



female pharmacist

Ivana Rizk El Maalouf, PHARMACIST


Pharmacist
423 W Broadway, South Boston, MA 02127
617-269-7656    

female pharmacist

Kathleen L. Golden, RPH


Pharmacist
710 East Broadway, South Boston, MA 02127
617-296-5788     617-269-4462

female pharmacist

Kathleen Hill, RPH


Pharmacist
423 W Broadway, South Boston, MA 02127
617-269-7656    

male pharmacist

Kayla Yates


Pharmacist
409 W Broadway, South Boston, MA 02127
617-766-9038    

male pharmacist

Dr. Kenneth Malcolm Oconnell, PHARM D


Pharmacist
710 E Broadway, South Boston, MA 02127
617-269-5780     617-269-4462

female pharmacist

Madison Thompson, PHARMD


Pharmacist
423 W Broadway, South Boston, MA 02127
617-269-7656    

female pharmacist

Marie D'angelo


Pharmacist
710 E Broadway, South Boston, MA 02127
617-269-5788    

male pharmacist

Mohammad Shakeri


Pharmacist
710 E Broadway, South Boston, MA 02127
617-269-5788    

male pharmacist

Steven Thomas Eggleston, PHARMD


Pharmacist
423 W Broadway, South Boston, MA 02127
617-269-7656    

female pharmacist

Tu-tram T Dao


Pharmacist
710 E Broadway, South Boston, MA 02127
617-269-5788    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.